IL158013A0 - Disease-associated protein - Google Patents

Disease-associated protein

Info

Publication number
IL158013A0
IL158013A0 IL15801302A IL15801302A IL158013A0 IL 158013 A0 IL158013 A0 IL 158013A0 IL 15801302 A IL15801302 A IL 15801302A IL 15801302 A IL15801302 A IL 15801302A IL 158013 A0 IL158013 A0 IL 158013A0
Authority
IL
Israel
Prior art keywords
disease
associated protein
protein
Prior art date
Application number
IL15801302A
Other languages
English (en)
Original Assignee
Novartis Ag
Univ Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Univ Pasteur filed Critical Novartis Ag
Publication of IL158013A0 publication Critical patent/IL158013A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15801302A 2001-04-06 2002-04-05 Disease-associated protein IL158013A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104712A FR2823221B1 (fr) 2001-04-06 2001-04-06 Sequences associees a la degenerescence retinienne et applications
PCT/EP2002/003810 WO2002081513A2 (en) 2001-04-06 2002-04-05 Disease-associated protein

Publications (1)

Publication Number Publication Date
IL158013A0 true IL158013A0 (en) 2004-03-28

Family

ID=8862037

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15801302A IL158013A0 (en) 2001-04-06 2002-04-05 Disease-associated protein
IL158013A IL158013A (en) 2001-04-06 2003-09-18 Isolated polypeptide and pharmaceutical composition comprising it for the diagnosis of retinal dystrophy and use thereof in the preparation of a medicament for the treatment of retinal dystrophy
IL199316A IL199316A (en) 2001-04-06 2009-06-11 An antibody is cleared and a kit that includes it for diagnosing retinal dystrophy

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL158013A IL158013A (en) 2001-04-06 2003-09-18 Isolated polypeptide and pharmaceutical composition comprising it for the diagnosis of retinal dystrophy and use thereof in the preparation of a medicament for the treatment of retinal dystrophy
IL199316A IL199316A (en) 2001-04-06 2009-06-11 An antibody is cleared and a kit that includes it for diagnosing retinal dystrophy

Country Status (22)

Country Link
US (6) US7795387B2 (enExample)
EP (1) EP1379657B1 (enExample)
JP (2) JP4370428B2 (enExample)
KR (1) KR100913258B1 (enExample)
CN (1) CN1529753B (enExample)
AU (1) AU2002312794B8 (enExample)
BR (1) BRPI0208870B8 (enExample)
CA (1) CA2443345C (enExample)
CZ (1) CZ305800B6 (enExample)
EC (1) ECSP024345A (enExample)
ES (1) ES2597835T3 (enExample)
FR (1) FR2823221B1 (enExample)
HU (1) HU226307B1 (enExample)
IL (3) IL158013A0 (enExample)
MX (1) MXPA03009114A (enExample)
NO (1) NO331277B1 (enExample)
NZ (1) NZ528376A (enExample)
PL (1) PL213658B1 (enExample)
RU (1) RU2384586C2 (enExample)
SK (1) SK288465B6 (enExample)
WO (1) WO2002081513A2 (enExample)
ZA (1) ZA200307403B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
PT1625210E (pt) 2003-05-21 2011-03-15 Genzyme Corp Métodos para produzir preparações de vírions de aav recombinantes substancialmente livres de capsídeos vazios
FR2870241B1 (fr) * 2004-05-13 2015-02-27 Novartis Ag Facteur de viabilite des cones derive des batonnets ou rdcvf et applications
EP2027889A1 (en) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) New neuronal viability factor and use thereof
WO2009146183A1 (en) * 2008-04-15 2009-12-03 Genzyme Corporation Methods to produce rod-derived cone viability factor (rdcvf)
WO2010029130A1 (en) * 2008-09-10 2010-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Neuronal viability factor and use thereof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
DK2797613T3 (da) 2011-10-27 2020-03-02 Wellstat Ophthalmics Corp Vektorer, der koder for rod-derived cone viability-faktor
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
WO2014060517A1 (en) * 2012-10-17 2014-04-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (amd)
PL3412684T3 (pl) 2013-07-31 2022-08-08 Novartis Ag Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarzy
JP6684343B2 (ja) 2015-05-21 2020-04-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ニューロン生存因子の相乗組み合わせ及びその使用
WO2017120294A1 (en) 2016-01-05 2017-07-13 The Trustees Of The University Of Pennsylvania Methods and compositions for treatment of ocular disorders and blinding diseases
GB201603987D0 (en) 2016-03-08 2016-04-20 Immatics Biotechnologies Gmbh Uterine cancer treatments
US10946063B2 (en) 2016-10-11 2021-03-16 Welltat Ophthalmics Corporation Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
JP7495756B2 (ja) * 2019-12-09 2024-06-05 北京中因科技有限公司 医薬の製造におけるＣＹＰ４Ｖ２およびＲｄＣＶＦの使用
CN111733174B (zh) * 2020-08-07 2021-02-09 北京大学第三医院（北京大学第三临床医学院） 一种分离的核酸分子及其用途
US20250276088A1 (en) * 2021-07-07 2025-09-04 Institut National de la Santé et de la Recherche Médicale Synergistic combination of rdcfv2 and rdcvf2l for the treatment of tauopathies
CN113774019B (zh) * 2021-08-11 2024-02-13 东南大学 一种脐带血间充质干细胞无血清培养基、培养方法及其应用
WO2024206928A1 (en) 2023-03-30 2024-10-03 Pharma Cinq, Llc VECTOR ENCODING ROD-DERIVED CONE VIABILITY FACTOR AND HUMAN IgK SIGNAL SEQUENCE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771036A (en) * 1986-02-10 1988-09-13 Trustees Of Columbia University In The City Of New York Method and ophthalmic composition for the prevention and reversal of cataracts
GB9701710D0 (en) 1997-01-28 1997-03-19 Karobio Ab Mammalian protein
US6106825A (en) * 1997-05-07 2000-08-22 University Of Florida Entomopoxvirus-vertebrate gene delivery vector and method
FR2784030B1 (fr) * 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2784898A1 (fr) * 1998-10-26 2000-04-28 Univ Pasteur Utilisation du gdnf pour le traitement de la degenerescence retinienne
EP1033405A3 (en) * 1999-02-25 2001-08-01 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
WO2010029130A1 (en) 2008-09-10 2010-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Neuronal viability factor and use thereof

Also Published As

Publication number Publication date
NO331277B1 (no) 2011-11-14
MXPA03009114A (es) 2004-11-22
US20130287738A1 (en) 2013-10-31
AU2002312794B8 (en) 2006-01-12
ECSP024345A (es) 2004-06-28
CZ305800B6 (cs) 2016-03-23
PL213658B1 (pl) 2013-04-30
WO2002081513A3 (en) 2003-05-01
US8114849B2 (en) 2012-02-14
RU2003130638A (ru) 2005-04-20
FR2823221B1 (fr) 2004-04-02
SK12232003A3 (sk) 2004-03-02
US7795387B2 (en) 2010-09-14
US8518695B2 (en) 2013-08-27
NO20034452L (no) 2003-12-04
US8394756B2 (en) 2013-03-12
CA2443345C (en) 2012-12-04
CN1529753A (zh) 2004-09-15
WO2002081513A2 (en) 2002-10-17
US20120108657A1 (en) 2012-05-03
US8957043B2 (en) 2015-02-17
BR0208870A (pt) 2004-04-27
CZ20032706A3 (cs) 2003-12-17
US20120108523A1 (en) 2012-05-03
ES2597835T3 (es) 2017-01-23
NO20034452D0 (no) 2003-10-03
ZA200307403B (en) 2004-04-21
HUP0303730A2 (en) 2006-02-28
KR20030094317A (ko) 2003-12-11
JP4571695B2 (ja) 2010-10-27
IL199316A (en) 2011-01-31
US20090062188A1 (en) 2009-03-05
EP1379657B1 (en) 2016-08-17
SK288465B6 (sk) 2017-06-02
BRPI0208870B1 (pt) 2016-01-12
HU226307B1 (en) 2008-08-28
NZ528376A (en) 2005-09-30
JP4370428B2 (ja) 2009-11-25
AU2002312794B2 (en) 2005-12-01
CA2443345A1 (en) 2002-10-17
RU2384586C2 (ru) 2010-03-20
US8071745B2 (en) 2011-12-06
CN1529753B (zh) 2013-06-12
EP1379657A2 (en) 2004-01-14
BRPI0208870B8 (pt) 2021-05-25
US20080004231A1 (en) 2008-01-03
US20040204350A1 (en) 2004-10-14
PL364681A1 (en) 2004-12-13
JP2009232843A (ja) 2009-10-15
KR100913258B1 (ko) 2009-08-21
IL158013A (en) 2010-12-30
FR2823221A1 (fr) 2002-10-11
JP2005502319A (ja) 2005-01-27

Similar Documents

Publication Publication Date Title
GB0130228D0 (en) Protein
IL158013A0 (en) Disease-associated protein
EP1365022A4 (en) ADIPONECTIN-ASSOCIATED PROTEIN
GB0130557D0 (en) Proteins
GB0108079D0 (en) Protein
GB0130720D0 (en) Proteins
EP1373306A4 (en) PROTEINS ASSOCIATED WITH CYTOSKELETON
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0130560D0 (en) Proteins
GB0130721D0 (en) Protein
GB0106318D0 (en) Protein
HK1061692A (en) Disease-associated protein
GB0130743D0 (en) Proteins
GB0130719D0 (en) Proteins
GB0130739D0 (en) Proteins
GB0126787D0 (en) Proteins
GB0120557D0 (en) Proteins
GB0114313D0 (en) Proteins
GB0111303D0 (en) Proteins
GB0108895D0 (en) Proteins
GB0108472D0 (en) Proteins
GB0130722D0 (en) Proteins
GB0130742D0 (en) Proteins
GB0128596D0 (en) Proteins
GB0128374D0 (en) Proteins